{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T13:04:23Z","timestamp":1791896663465,"version":"4.3.4"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T00:00:00Z","timestamp":1768780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T00:00:00Z","timestamp":1768780800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Urol"],"DOI":"10.1007\/s00345-025-06172-5","type":"journal-article","created":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T19:14:36Z","timestamp":1768850076000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["The median lobe scenario. How to tackle this challenge best: systematic review and expert guidance"],"prefix":"10.1007","volume":"44","author":[{"given":"Aamer","family":"Alghamlas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Othmane","family":"Zekraoui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas R. W.","family":"Herrmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominik","family":"Abt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thorsten","family":"Bach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bilal","family":"Chughtai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dean","family":"Elterman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selcuk","family":"Guven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahyai","family":"Sascha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioannis","family":"Kartalas-Goumas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cesare Marco","family":"Scoffone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naeem","family":"Bhojani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,19]]},"reference":[{"key":"6172_CR1","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.ucl.2016.04.001","volume":"43","author":"KB Egan","year":"2016","unstructured":"Egan KB (2016) The epidemiology of benign prostatic hyperplasia associated with lower urinary tract symptoms: prevalence and incident rates. Urol Clin N Am 43:289\u2013297. https:\/\/doi.org\/10.1016\/j.ucl.2016.04.001","journal-title":"Urol Clin N Am"},{"key":"6172_CR2","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.ajur.2017.06.004","volume":"4","author":"KB Lim","year":"2017","unstructured":"Lim KB (2017) Epidemiology of clinical benign prostatic hyperplasia. Asian J Urol 4:148\u2013151. https:\/\/doi.org\/10.1016\/j.ajur.2017.06.004","journal-title":"Asian J Urol"},{"key":"6172_CR3","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1007\/s11884-010-0067-2","volume":"5","author":"JK Parsons","year":"2010","unstructured":"Parsons JK (2010) Benign prostatic hyperplasia and male lower urinary tract symptoms: epidemiology and risk factors. Curr Bladder Dysfunct Rep 5:212\u2013218. https:\/\/doi.org\/10.1007\/s11884-010-0067-2","journal-title":"Curr Bladder Dysfunct Rep"},{"key":"6172_CR4","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1080\/13685538.2018.1433654","volume":"21","author":"M Erkoc","year":"2018","unstructured":"Erkoc M, Otunctemur A, Besiroglu H, Altunrende F (2018) Evaluation of quality of life in patients undergoing surgery for benign prostatic hyperplasia. Aging Male 21:238\u2013242. https:\/\/doi.org\/10.1080\/13685538.2018.1433654","journal-title":"Aging Male"},{"key":"6172_CR5","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.urology.2019.07.039","volume":"134","author":"NC Sabharwal","year":"2019","unstructured":"Sabharwal NC, Shoskes DA, Dielubanza EJ et al (2019) Comparative effectiveness of transurethral prostate procedures at enabling urologic medication discontinuation: a retrospective analysis. Urology 134:192\u2013198. https:\/\/doi.org\/10.1016\/j.urology.2019.07.039","journal-title":"Urology"},{"key":"6172_CR6","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.ajur.2015.11.003","volume":"3","author":"KT Foo","year":"2016","unstructured":"Foo KT (2016) Solving the benign prostatic hyperplasia puzzle. Asian J Urol 3:6\u20139. https:\/\/doi.org\/10.1016\/j.ajur.2015.11.003","journal-title":"Asian J Urol"},{"key":"6172_CR7","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1046\/j.1464-410x.2003.04088.x","volume":"91","author":"SJ Chia","year":"2003","unstructured":"Chia SJ, Heng CT, Chan SP, Foo KT (2003) Correlation of intravesical prostatic protrusion with bladder outlet obstruction. BJU Int 91:371\u2013374. https:\/\/doi.org\/10.1046\/j.1464-410x.2003.04088.x","journal-title":"BJU Int"},{"key":"6172_CR8","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s12894-018-0320-0","volume":"18","author":"L Topazio","year":"2018","unstructured":"Topazio L, Perugia C, De Nunzio C et al (2018) Intravescical prostatic protrusion is a predictor of alpha blockers response: results from an observational study. BMC Urol 18:6. https:\/\/doi.org\/10.1186\/s12894-018-0320-0","journal-title":"BMC Urol"},{"key":"6172_CR9","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.urology.2015.11.029","volume":"88","author":"A Kalkanli","year":"2016","unstructured":"Kalkanli A, Tandogdu Z, Aydin M et al (2016) Intravesical prostatic protrusion: a potential marker of alpha-blocker treatment success in patients with benign prostatic enlargement. Urology 88:161\u2013165. https:\/\/doi.org\/10.1016\/j.urology.2015.11.029","journal-title":"Urology"},{"key":"6172_CR10","doi-asserted-by":"publisher","first-page":"695","DOI":"10.21037\/tau.2017.07.30","volume":"6","author":"C Welliver","year":"2017","unstructured":"Welliver C, Helo S, McVary KT (2017) Technique considerations and complication management in transurethral resection of the prostate and photoselective vaporization of the prostate. Transl Androl Urol 6:695\u2013703. https:\/\/doi.org\/10.21037\/tau.2017.07.30","journal-title":"Transl Androl Urol"},{"key":"6172_CR11","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.11124\/JBISRIR-D-19-00099","volume":"18","author":"Z Munn","year":"2020","unstructured":"Munn Z, Barker TH, Moola S et al (2020) Methodological quality of case series studies: an introduction to the JBI critical appraisal tool. JBI Evid Synth 18:2127\u20132133. https:\/\/doi.org\/10.11124\/JBISRIR-D-19-00099","journal-title":"JBI Evid Synth"},{"key":"6172_CR12","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372:n71. https:\/\/doi.org\/10.1136\/bmj.n71","journal-title":"BMJ"},{"key":"6172_CR13","doi-asserted-by":"publisher","first-page":"e0138237","DOI":"10.1371\/journal.pone.0138237","volume":"10","author":"NR Haddaway","year":"2015","unstructured":"Haddaway NR, Collins AM, Coughlin D, Kirk S (2015) The role of Google scholar in evidence reviews and its applicability to grey literature searching. PLoS One 10:e0138237. https:\/\/doi.org\/10.1371\/journal.pone.0138237","journal-title":"PLoS One"},{"key":"6172_CR14","doi-asserted-by":"publisher","first-page":"l4898","DOI":"10.1136\/bmj.l4898","volume":"366","author":"JAC Sterne","year":"2019","unstructured":"Sterne JAC, Savovi\u0107 J, Page MJ et al (2019) RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ 366:l4898. https:\/\/doi.org\/10.1136\/bmj.l4898","journal-title":"BMJ"},{"key":"6172_CR15","doi-asserted-by":"publisher","first-page":"i4919","DOI":"10.1136\/bmj.i4919","volume":"355","author":"JA Sterne","year":"2016","unstructured":"Sterne JA, Hern\u00e1n MA, Reeves BC et al (2016) ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ 355:i4919. https:\/\/doi.org\/10.1136\/bmj.i4919","journal-title":"BMJ"},{"key":"6172_CR16","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.urology.2021.01.025","volume":"154","author":"MJ Rabinowitz","year":"2021","unstructured":"Rabinowitz MJ, Alam R, Liu JL et al (2021) Prostatic urethral lift in patients with obstructive median lobes: a single surgeon experience at an academic center. Urology 154:237\u2013242. https:\/\/doi.org\/10.1016\/j.urology.2021.01.025","journal-title":"Urology"},{"key":"6172_CR17","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.urology.2019.07.042","volume":"134","author":"Z Gul","year":"2019","unstructured":"Gul Z, Chughtai B, Te AE et al (2019) Ejaculatory preserving middle lobe onl-transurethral resection and vaporization of the prostate: 12-year experience. Urology 134:199\u2013202. https:\/\/doi.org\/10.1016\/j.urology.2019.07.042","journal-title":"Urology"},{"key":"6172_CR18","doi-asserted-by":"publisher","first-page":"3881","DOI":"10.1007\/s00345-020-03529-w","volume":"39","author":"D-D Nguyen","year":"2021","unstructured":"Nguyen D-D, Sadri I, Law K et al (2021) Impact of the presence of a median lobe on functional outcomes of greenlight photovaporization of the prostate (PVP): an analysis of the global greenlight group (GGG) database. World J Urol 39:3881\u20133889. https:\/\/doi.org\/10.1007\/s00345-020-03529-w","journal-title":"World J Urol"},{"key":"6172_CR19","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.urology.2022.12.035","volume":"173","author":"B Press","year":"2023","unstructured":"Press B, Gardezi M, Kim DD et al (2023) Ejaculatory preserving holmium laser enucleation of the median lobe: preserving sexual function while improving urinary outcomes. Urology 173:175\u2013179. https:\/\/doi.org\/10.1016\/j.urology.2022.12.035","journal-title":"Urology"},{"key":"6172_CR20","doi-asserted-by":"publisher","first-page":"102581","DOI":"10.1016\/j.fjurol.2024.102581","volume":"34","author":"T Long Depaquit","year":"2024","unstructured":"Long Depaquit T, Baboudjian M, Chiron P et al (2024) Modified holmium laser enucleation for benign prostatic obstruction to preserve sexual and ejaculatory function. Fr J Urol 34:102581. https:\/\/doi.org\/10.1016\/j.fjurol.2024.102581","journal-title":"Fr J Urol"},{"key":"6172_CR21","doi-asserted-by":"publisher","first-page":"E39","DOI":"10.5489\/cuaj.7890","volume":"17","author":"A Nevo","year":"2023","unstructured":"Nevo A, Cheney SM, Callegari M et al (2023) Median lobe vs. complete gland holmium laser enucleation of the prostate: a propensity score matching. Can Urol Assoc J 17:E39\u2013E43. https:\/\/doi.org\/10.5489\/cuaj.7890","journal-title":"Can Urol Assoc J"},{"key":"6172_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.urology.2017.10.023","volume":"111","author":"KT McVary","year":"2018","unstructured":"McVary KT, Roehrborn CG (2018) Three-Year outcomes of the Prospective, randomized controlled Rez\u016bm system study: convective radiofrequency thermal therapy for treatment of lower urinary tract symptoms due to benign prostatic hyperplasia. Urology 111:1\u20139. https:\/\/doi.org\/10.1016\/j.urology.2017.10.023","journal-title":"Urology"},{"key":"6172_CR23","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.urology.2022.02.001","volume":"165","author":"D Elterman","year":"2022","unstructured":"Elterman D, Bhojani N, Vannabouathong C et al (2022) Large, multi-center, prospective registry of Rez\u016bm water vapor therapy for benign prostatic hyperplasia. Urology 165:261\u2013267. https:\/\/doi.org\/10.1016\/j.urology.2022.02.001","journal-title":"Urology"},{"key":"6172_CR24","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/s41391-017-0022-9","volume":"21","author":"D Mollengarden","year":"2018","unstructured":"Mollengarden D, Goldberg K, Wong D, Roehrborn C (2018) Convective radiofrequency water vapor thermal therapy for benign prostatic hyperplasia: a single office experience. Prostate Cancer Prostatic Dis 21:379\u2013385. https:\/\/doi.org\/10.1038\/s41391-017-0022-9","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"6172_CR25","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1002\/pros.24201","volume":"81","author":"D Bassily","year":"2021","unstructured":"Bassily D, Wong V, Phillips JL et al (2021) Rez\u016bm for retention-retrospective review of water vaporization therapy in the management of urinary retention in men with benign prostatic hyperplasia. Prostate 81:1049\u20131054. https:\/\/doi.org\/10.1002\/pros.24201","journal-title":"Prostate"},{"key":"6172_CR26","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1097\/JU.0000000000003483","volume":"210","author":"N Bhojani","year":"2023","unstructured":"Bhojani N, Bidair M, Kramolowsky E et al (2023) Aquablation therapy in large prostates (80\u2013150 mL) for lower urinary tract symptoms due to benign prostatic hyperplasia: final WATER II 5-Year clinical trial results. J Urol 210:143\u2013153. https:\/\/doi.org\/10.1097\/JU.0000000000003483","journal-title":"J Urol"},{"key":"6172_CR27","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/s41391-018-0118-x","volume":"22","author":"D Rukstalis","year":"2019","unstructured":"Rukstalis D, Grier D, Stroup SP et al (2019) Prostatic urethral lift (PUL) for obstructive median lobes: 12 month results of the medlift study. Prostate Cancer Prostatic Dis 22:411\u2013419. https:\/\/doi.org\/10.1038\/s41391-018-0118-x","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"6172_CR28","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1111\/luts.12397","volume":"13","author":"V Vanalderwerelt","year":"2021","unstructured":"Vanalderwerelt V, Prad\u00e8re B, Grevez T et al (2021) Influence of the median lobe on the results at 4 years of the prostate vaporization by greenlight laser. Low Urin Tract Symptoms 13:475\u2013480. https:\/\/doi.org\/10.1111\/luts.12397","journal-title":"Low Urin Tract Symptoms"},{"key":"6172_CR29","doi-asserted-by":"publisher","unstructured":"Kasraeian A (2019) Single surgeon experience with procept aquabeam aquablation of prostate: first 40 cases. J Endourol 2019;33(Supplement 1):A103EP - A104. https:\/\/doi.org\/10.1089\/end.2019.29064.abstracts","DOI":"10.1089\/end.2019.29064.abstracts"},{"key":"6172_CR30","doi-asserted-by":"publisher","unstructured":"alkadhi O, Aho TF (2012) Perioperative outcomes and durability of holmium laser enucleation of the median lobe of the prostate (HoLEMP). J Endouro 2012;26(SUPPL. 1):A269. https:\/\/doi.org\/10.1089\/end.2012.2001D","DOI":"10.1089\/end.2012.2001"},{"key":"6172_CR31","unstructured":"Jiang J, Khanmammadova N, Park E et al (2024) Ejaculation-preserving partial HoLEP: a case series on balancing sexual and urinary function. J Endourol A188"},{"key":"6172_CR32","unstructured":"Stern K, Tyson M, Humphreys M, McAdams S (2016) Holmium laser enucleation of the prostate: a median lobe-only technique. J Endourol"},{"key":"6172_CR33","doi-asserted-by":"publisher","first-page":"743","DOI":"10.23736\/S2724-6051.23.05322-3","volume":"75","author":"D Amparore","year":"2023","unstructured":"Amparore D, De Cillis S, Schulman C et al (2023) Temporary implantable nitinol device for benign prostatic hyperplasia-related lower urinary tract symptoms: over 48-month results. Minerva Urol Nephrol 75:743\u2013751. https:\/\/doi.org\/10.23736\/S2724-6051.23.05322-3","journal-title":"Minerva Urol Nephrol"},{"key":"6172_CR34","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.urology.2020.12.022","volume":"153","author":"B Chughtai","year":"2021","unstructured":"Chughtai B, Elterman D, Shore N et al (2021) The iTind temporarily implanted nitinol device for the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia: a multicenter, randomized, controlled trial. Urology 153:270\u2013276. https:\/\/doi.org\/10.1016\/j.urology.2020.12.022","journal-title":"Urology"},{"key":"6172_CR35","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1038\/s41391-021-00362-z","volume":"24","author":"SA Kaplan","year":"2021","unstructured":"Kaplan SA, Pichardo M, Rijo E et al (2021) One-year outcomes after treatment with a drug-coated balloon catheter system for lower urinary tract symptoms related to benign prostatic hyperplasia. Prostate Cancer Prostatic Dis 24:1073\u20131079. https:\/\/doi.org\/10.1038\/s41391-021-00362-z","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"6172_CR36","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1097\/JU.0000000000003568","volume":"210","author":"SA Kaplan","year":"2023","unstructured":"Kaplan SA, Moss J, Freedman S et al (2023) The PINNACLE study: a double-blind, randomized, sham-controlled study evaluating the optilume BPH catheter system for the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia. J Urol 210:500\u2013509. https:\/\/doi.org\/10.1097\/JU.0000000000003568","journal-title":"J Urol"},{"key":"6172_CR37","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1111\/bju.14608","volume":"123","author":"F Porpiglia","year":"2019","unstructured":"Porpiglia F, Fiori C, Amparore D et al (2019) Second-generation of temporary implantable nitinol device for the relief of lower urinary tract symptoms due to benign prostatic hyperplasia: results of a prospective, multicentre study at 1 year of follow-up. BJU Int 123:1061\u20131069. https:\/\/doi.org\/10.1111\/bju.14608","journal-title":"BJU Int"},{"key":"6172_CR38","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1089\/089277904322959842","volume":"18","author":"RM Kuntz","year":"2004","unstructured":"Kuntz RM, Lehrich K, Ahyai S (2004) Does perioperative outcome of transurethral holmium laser enucleation of the prostate depend on prostate size? J Endourol 18:183\u2013188. https:\/\/doi.org\/10.1089\/089277904322959842","journal-title":"J Endourol"},{"key":"6172_CR39","doi-asserted-by":"publisher","first-page":"265","DOI":"10.3109\/00365591003645712","volume":"44","author":"M Hojgaard","year":"2010","unstructured":"Hojgaard M, Mikines KJ (2010) Ureteral injuries during photoselective vaporization of the prostate. Scand J Urol Nephrol 44:265\u2013268. https:\/\/doi.org\/10.3109\/00365591003645712","journal-title":"Scand J Urol Nephrol"}],"container-title":["World Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-025-06172-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00345-025-06172-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-025-06172-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T19:14:37Z","timestamp":1768850077000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00345-025-06172-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,19]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["6172"],"URL":"https:\/\/doi.org\/10.1007\/s00345-025-06172-5","relation":{},"ISSN":["1433-8726"],"issn-type":[{"value":"1433-8726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,19]]},"assertion":[{"value":"19 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Dr. Chughtai is a paid consultant for Boston Scientific Corporation, Olympus, and Prodeon Medical. Dr.Bhojani and Dr.Elterman are paid consultants for Boston Scientific Corporation, Olympus, and Procept BioRobotics. The remains authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}],"article-number":"114"}}